Clinical Trial: A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma

Saved in:
Bibliographic Details
Published inUS Fed News Service, Including US State News
Format Newsletter
LanguageEnglish
Published Washington, D.C HT Digital Streams Limited 11.05.2015
Online AccessGet full text

Cover

More Information
Description not available.